Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Irritable Bowel Syndrome

Free Subscription 16.09.2019 1 Acta Endocrinol (Buchar) 1 Antiinflamm Antiallergy Agents Med Chem 1 Dig Dis Sci 1 Eur J Nutr 1 Eur J Pharmacol 1 FEBS J 1 Front Microbiol 1 Front Physiol 1 Int J Trichology 1 J Clin Gastroenterol 1 J Nerv Ment Dis 1 J Physiol 1 J Psychosom Res 1 Mucosal Immunol 3 Neurogastroenterol Motil 2 Nutrients 1 World J Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Acta Endocrinol (Buchar)

1. BALMUS IM, Robea M, Ciobica A, Timofte D, et al
   PERCEIVED STRESS AND GASTROINTESTINAL HABITS IN COLLEGE STUDENTS.
   Acta Endocrinol (Buchar). 2019;15:274-275.
   PubMed     Text format     Abstract available
   
   

   
   Antiinflamm Antiallergy Agents Med Chem

2. MADIA VN, Messore A, Saccoliti F, Tudino V, et al
   Tegaserod for the Treatment of Irritable Bowel Syndrome.
   Antiinflamm Antiallergy Agents Med Chem. 2019 Sep 11. pii: AIAAMC-EPUB-100728.
   PubMed     Text format     Abstract available
   
   

   
   Dig Dis Sci

3. CHIARIONI G
   Concise Commentary: Bloating Makes a Comeback in IBS.
   Dig Dis Sci. 2019;64:1296.
   PubMed     Text format    
   
   

   
   Eur J Nutr

4. NAWAWI KNM, Belov M, Goulding C
   Low FODMAP diet significantly improves IBS symptoms: an Irish retrospective cohort study.
   Eur J Nutr. 2019 Sep 13. pii: 10.1007/s00394-019-02074.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Pharmacol

5. SALAGA M, Binienda A, Tichkule RB, Thakur GA, et al
   Corrigendum to "The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome" [Eur. J. Pharmacol. (2018),
   Eur J Pharmacol. 2019 Sep 10:172656. doi: 10.1016/j.ejphar.2019.172656.
   PubMed     Text format    
   
   

   
   FEBS J

6. PONTAROLLO G, Mann A, Brandao I, Malinarich F, et al
   Protease-activated receptor signaling in intestinal permeability regulation.
   FEBS J. 2019 Sep 8. doi: 10.1111/febs.15055.
   PubMed     Text format     Abstract available
   
   

   
   Front Microbiol

7. GU Y, Zhou G, Qin X, Huang S, et al
   The Potential Role of Gut Mycobiome in Irritable Bowel Syndrome.
   Front Microbiol. 2019;10:1894.
   PubMed     Text format     Abstract available
   
   

   
   Front Physiol

8. DU Q, Liao Q, Chen C, Yang X, et al
   The Role of Transient Receptor Potential Vanilloid 1 in Common Diseases of the Digestive Tract and the Cardiovascular and Respiratory System.
   Front Physiol. 2019;10:1064.
   PubMed     Text format     Abstract available
   
   

   
   Int J Trichology

9. THOMPSON KG, Marchitto MC, Ly BCK, Chien AL, et al
   Evaluation of Physiological, Psychological, and Lifestyle Factors Associated with Premature Hair Graying.
   Int J Trichology. 2019;11:153-158.
   PubMed     Text format     Abstract available
   
   

   
   J Clin Gastroenterol

10. DONG Y, Baumeister D, Berens S, Eich W, et al
    Stressful Life Events Moderate the Relationship Between Changes in Symptom Severity and Health-related Quality of Life in Patients With Irritable Bowel Syndrome.
    J Clin Gastroenterol. 2019 Sep 9. doi: 10.1097/MCG.0000000000001261.
    PubMed     Text format     Abstract available
    
    

    
    J Nerv Ment Dis

11. HAJJ A, Mourad D, Ghossoub M, Hallit S, et al
    Uncovering Demographic, Clinical, Triggering Factors Similarities Between Migraine and Irritable Bowel Syndrome: A Prospective Study.
    J Nerv Ment Dis. 2019 Sep 9. doi: 10.1097/NMD.0000000000001033.
    PubMed     Text format     Abstract available
    
    

    
    J Physiol

12. KONTHAPAKDEE N, Grundy L, O'Donnell T, Garcia-Caraballo S, et al
    Serotonin exerts a direct modulatory role on bladder afferent firing in mice.
    J Physiol. 2019 Sep 14. doi: 10.1113/JP278751.
    PubMed     Text format     Abstract available
    
    

    
    J Psychosom Res

13. LACHANCE CC, McCormack S, Kamp KJ, Weaver KR, et al
    Effects of a comprehensive self-management intervention on extraintestinal symptoms among patients with IBS.
    J Psychosom Res. 2019;126:109821.
    PubMed     Text format     Abstract available
    
    

    
    Mucosal Immunol

14. HASSAN E, Baldridge MT
    Norovirus encounters in the gut: multifaceted interactions and disease outcomes.
    Mucosal Immunol. 2019 Sep 9. pii: 10.1038/s41385-019-0199.
    PubMed     Text format     Abstract available
    
    

    
    Neurogastroenterol Motil

15. ROBLES A, Perez Ingles D, Myneedu K, Deoker A, et al
    Mast cells are increased in the small intestinal mucosa of patients with irritable bowel syndrome: A systematic review and meta-analysis.
    Neurogastroenterol Motil. 2019 Sep 9:e13718. doi: 10.1111/nmo.13718.
    PubMed     Text format     Abstract available
    
    
16. ROSSI G, Gioacchini G, Pengo G, Suchodolski JS, et al
    Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical improvement after probiotic administration in dogs with chronic signs of colonic dysmotility without mucosal inflammatory changes.
    Neurogastroenterol Motil. 2019 Sep 8:e13717. doi: 10.1111/nmo.13717.
    PubMed     Text format     Abstract available
    
    
17. SUNDIN J, Nordlander S, Eutamene H, Alquier-Bacquie V, et al
    Colonic mast cell numbers, symptom profile, and mucosal expression of elements of the epithelial barrier in irritable bowel syndrome.
    Neurogastroenterol Motil. 2019 Sep 13:e13701. doi: 10.1111/nmo.13701.
    PubMed     Text format     Abstract available
    
    

    
    Nutrients

18. ALGERA J, Colomier E, Simren M
    The Dietary Management of Patients with Irritable Bowel Syndrome: A Narrative Review of the Existing and Emerging Evidence.
    Nutrients. 2019;11.
    PubMed     Text format     Abstract available
    
    
19. YASUKAWA Z, Inoue R, Ozeki M, Okubo T, et al
    Effect of Repeated Consumption of Partially Hydrolyzed Guar Gum on Fecal Characteristics and Gut Microbiota: A Randomized, Double-Blind, Placebo-Controlled, and Parallel-Group Clinical Trial.
    Nutrients. 2019;11.
    PubMed     Text format     Abstract available
    
    

    
    World J Gastroenterol

20. BARROS LL, Farias AQ, Rezaie A
    Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment.
    World J Gastroenterol. 2019;25:4414-4426.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Irritable Bowel Syndrome is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: